Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (65)
  • 2025 (210)
  • 2024 (224)
  • 2023 (292)
  • 2022 (419)
  • 2021 (135)
  • 2020 (10)
  • 2019 (5)
  • 2017 (6)

Subject

  • Drug Trafficking (4206)
  • Guns/Weapons (1039)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (644)
  • Guilty Plea (558)
  • Seizures (Drugs/Property) (482)
  • Prescription Drugs (371)
  • Overdose (327)
  • Major Law Enforcement Operation (277)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (237)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (188)
  • Fentanyl Awareness (166)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (68)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (39)
  • Counterfeit Pills (38)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (13)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Synthetic drugs (1140)
  • Diversion Division (254)

Drug Name

  • Fentanyl (713)
  • Methamphetamine (479)
  • Heroin (250)
  • Cocaine (240)
  • Synthetic Opioids (72)
  • Opioids (67)
  • Oxycodone (57)
  • Marijuana (Cannabis) (35)
  • Hydromorphone (18)
  • Benzodiazepines (11)
  • Ecstasy/MDMA (9)
  • Morphine (9)
  • Amphetamines (6)
  • K2/Spice (4)
  • Ketamine (4)
  • Marijuana Concentrates (4)
  • Methadone (4)
  • Synthetic Bath Salts or Designer Cathinones (4)
  • Steroids (3)
  • Xylazine (3)
  • Psilocybin (2)
  • LSD (1)

Field Division

  • Seattle (329)
  • Washington, DC (194)
  • New York (184)
  • San Francisco (118)
  • Houston (87)
  • El Paso (85)
  • Chicago (69)
  • Miami (63)
  • New England (37)
  • New Jersey (36)
  • Atlanta (32)
  • Sede (25)
  • Los Angeles (23)
  • Dallas (15)
  • St. Louis (12)
  • Louisville (11)
  • New Orleans (10)
  • Phoenix (10)
  • Rocky Mountain (10)
  • Omaha (8)
  • San Diego (6)
  • Detroit (1)
Clear All Results
1366 Results - Showing 1341 to 1350
PRESS RELEASE

West Virginia Heroin Dealer Sentenced

Greenbelt, MD – U.S. District Judge Paul W. Grimm today sentenced Michael Bailey, age 32, of Winchester, Maryland, to 40 months in prison, followed by three years of supervised release, for possession of a firearm by a prohibited person. Bailey, a previously convicted felon, sold a firearm to a member...
PRESS RELEASE

DEA Launches Project Wave Breaker to Stop Flood of Deadly Fentanyl

EL PASO – Today the Drug Enforcement Administration announced a new initiative, Project Wave Breaker, to disrupt the flow of deadly fentanyl into the United States. Project Wave Breaker will direct interdiction, enforcement, and outreach efforts to the El Paso Division to disrupt the flow of fentanyl in and around...
PRESS RELEASE

Newport News Trafficker Pleads Guilty to Receiving Over 200 Kilograms of Cocaine

NEWPORT NEWS, Va. – A Newport News man pleaded guilty today to conspiring with members of an international drug trafficking organization to possess and distribute more than 200 kilograms of cocaine. According to court documents, Darrell King, II, 45, was a kilogram dealer of cocaine in the Tidewater area. Between...
PRESS RELEASE

Manager in Major Baltimore Drug Trafficking Organization Sentenced

Baltimore, MD – U.S. District Judge Paul W. Grimm sentenced Desmond Ringgold, a/k/a Worm and Fool, age 32, of Baltimore, Maryland to 15 years in federal prison, followed by five years of supervised release, for his role as a supervisor in a prolific drug trafficking organization (DTO) that operated in...
PRESS RELEASE

DEA 2020 Year in Review: Combatting Serious Drug-Related Threats During the Pandemic

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
PRESS RELEASE

DEA Implements Ecommerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...
PRESS RELEASE

Omnicare agrees to pay over $15 Million to resolve allegations it improperly dispensed opioids at long-term care facilities

PORTLAND, Ore.—Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by, among other things, allowing opioids and other controlled substances to be...

Paginación

  • Primera página «
  • Anterior
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Page 133
  • Page 134
  • Current page 135
  • Page 136
  • Page 137
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster